To investigate the effect of pharmacological inhibition of PIM kinases on the levels of H19 in T‐ALL cell lines, HSB‐2, DU.528, and CUTLL1 were treated with the pan‐PIM‐i AZ1208 (3 μm, 24 h). The gene discussed is H19; the disease is acute lymphoblastic leukemia.